Local 12: CVS, Walmart cut pharmacy hours due to staffing issues
UC expert says College of Pharmacy enrollment on positive trajectory
Walmart and CVS recently announced it is going to cut or shift pharmacy hours due to staffing issues, and Walgreens has already done so.
Kelly Epplen, associate dean of student affairs and admissions at the University of Cincinnati's James L. Winkle College of Pharmacy, told Local 12 pharmacy school enrollment numbers dropped about a decade ago after the job market became saturated. But now that trend is starting to shift, in part due to students being inspired to enter the profession after seeing pharmacists on the front line of the COVID-19 pandemic.
"As tragic as COVID has been globally and in our communities, pharmacists have really stepped it up and established their vital role in public health," Epplen said. "I see an upward tick and a positive trajectory."
Related Stories
Leukemia and Drug Development Lab trains the next generation of scientific researchers
December 15, 2025
From undergraduate student workers to members of the Physician Scientist Training Program (PSTP), trainees in UC's Leukemia and Drug Development Lab shared their experiences of in-depth, hands-on training that contribute to real-world discoveries.
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.